首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind placebo controlled study in healthy volunteers.
【2h】

Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind placebo controlled study in healthy volunteers.

机译:唑吡坦对眼跳运动和精神运动性能的影响:一项对健康志愿者进行的双盲安慰剂对照研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Peak saccade velocity provides a valuable means of assessing the sedative effect of drugs in humans. The present study investigated the effects of zolpidem, an imidazopyridine hypnotic, on saccade velocity in healthy volunteers after single and repeated administration. 2. Zolpidem 5 mg, 10 mg and 20 mg significantly and dose dependently depressed peak saccade velocity during the 1.5 h after a single administration. On the morning after zolpidem administration, peak saccade velocity had returned towards pretreatment levels. Nitrazepam 10 mg also significantly depressed peak saccade velocity but the effect was maintained the following morning. The saccade response to zolpidem (5 and 10 mg) was undiminished after the seven nightly doses. 3. Nightly administration of zolpidem improved subjective sleep quality and there was no evidence of rebound insomnia following cessation of drug treatment.
机译:1.峰值扫视速度为评估药物对人的镇静作用提供了一种有价值的手段。本研究调查了咪唑并吡啶催眠药唑吡坦对健康志愿者单次或重复给药后扫视速度的影响。 2.唑吡坦5 mg,10 mg和20 mg显着,剂量依赖性降低单次给药后1.5小时内的峰值扫视速度。服用唑吡坦后的早晨,扫视运动的峰值速度已恢复至治疗前的水平。硝西tra 10毫克也显着降低了峰值扫视速度,但第二天早晨就保持了这种效果。每晚七次服药后,对唑吡坦(5和10 mg)的扫视反应没有减弱。 3.每晚服用唑吡坦可以改善主观睡眠质量,并且没有停止药物治疗后出现反弹性失眠的迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号